Northwest Cancer Specialists Compass Oncology (36) — Portland, Oregon

Northwest Cancer Specialists Compass Oncology (36) is a clinical research site located in Portland, Oregon, United States 97210.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Northwest Cancer Specialists Compass Oncology (36) has participated in 1 clinical trials.

Therapeutic areas: PI3K Pathway Activated Tumors.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northwest Cancer Specialists Compass Oncology (36)?

Northwest Cancer Specialists Compass Oncology (36) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northwest Cancer Specialists Compass Oncology (36) conducted?

Northwest Cancer Specialists Compass Oncology (36) has 1 clinical trials on record. Their work covers PI3K Pathway Activated Tumors.

Is Northwest Cancer Specialists Compass Oncology (36) accredited by Crixeo Health?

Northwest Cancer Specialists Compass Oncology (36) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northwest Cancer Specialists Compass Oncology (36)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.